NRC (nrchealth.com) Utang jangka dawa

Tandha merek NRC Health (NRC)

Risks for National Research (NRC) are linked to reduced clinic spending on external experts, private data leaks, and clients transitioning to proprietary analysis systems. This price action confirms the status of a leader in treatment quality assessment trusted by leading US medical centers. Long-term debt stands at 0.08, while recurring software payments ensure high scalability and profit growth with minimal expenditures.

NRC (National Research) riwayat Utang jangka dawa perusahaan saka 04.07.2022 nganti 28.10.2026
Produk seri National Research

Long-term debts represent a collection of financial obligations with maturities exceeding one year, determining credit risk and the cost of capital. By analyzing a company's long-term liabilities, an investor assesses the resilience of the balance sheet structure against systemic liquidity shocks. This metric discounts future cash flows, thereby limiting free capital. For National Research (NRC), this is critical when scaling big data analytics and extending contracts with US hospitals.

Pesaing langsung

Kewajiban jangka dawa perusahaan veeva.com VEEV|DOCS (Doximity) - Utang jangka dawa perusahaan|HQY - Utang jangka dawa|Utang jangka dawa perusahaan Waystar Inc.|CRVL (CorVel Corp.) - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Privia Health Group (PRVA)|Tanggungan utang jangka dawa perusahaan huronconsultinggroup.com|Utang jangka dawa perusahaan CERT|Utang jangka dawa perusahaan Omnicell Inc OMCL|Kewajiban jangka dawa perusahaan GoodRx Corp (GDRX)|Gedhene kewajiban jangka dawa Schrodinger Corp SDGR|Utang jangka dawa perusahaan PHR (Phreesia, Inc.)|OMDA: Gunggunge utang jangka dawa|Utang jangka dawa perusahaan EVH|HSTM (HealthStream Inc) - Utang jangka dawa|Utang jangka dawa perusahaan Definitive Healthcare Inc. (DH)|Tanggungan utang jangka dawa perusahaan Consensus Corp|Utang jangka dawa perusahaan AGL|Utang jangka dawa perusahaan ABSI (absci.com)|Utang jangka dawa perusahaan So-Young International Inc. SY|SPOK - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan OptimizeRx Corp. (OPRX)|TBRG: Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Simulations Plus, Inc. SLP|SOPHiA GENETICS (SOPH) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan HCAT (Health Catalyst)|Utang jangka dawa CCLD|RSSS (Research Solutions) - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa dlhcorp.com (DLHC)|ONMD: Utang jangka dawa perusahaan|Utang jangka dawa scienture.com SCNX|Healthcare Triangle, Inc. - Utang jangka dawa perusahaan|ISPC: Utang jangka dawa perusahaan|Utang jangka dawa perusahaan bullfrogai.com BFRG|SCWorx Inc (WORX) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan MSPR|Kewajiban jangka dawa perusahaan iCoreConnect Corp|TRxADE HEALTH (MEDS) - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan ORGS (Orgenesis Inc)|RCM - Utang jangka dawa perusahaan|Sharecare Inc - Tanggungan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Streamline Health Solutions (STRM)|SYRA - Silihan lan utang jangka dawa perusahaan|AMEH (apollomed.net) - Utang jangka dawa perusahaan|Model N Inc (MODN) - Kewajiban jangka dawa perusahaan|NXGN: Utang jangka dawa perusahaan